CA Stock MarketDetailed Quotes

DTC Defence Therapeutics Inc

Watchlist
  • 0.590
  • 0.0000.00%
15min DelayPost Market Nov 8 15:49 ET
27.78MMarket Cap-1966P/E (TTM)

Defence Therapeutics Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2024
(Q4)Jun 30, 2024
(Q3)Mar 31, 2024
(Q2)Dec 31, 2023
(Q1)Sep 30, 2023
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(Q3)Mar 31, 2023
(Q2)Dec 31, 2022
(Q1)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
95.89%12.82M
-31.16%1.19M
-2.56%1.21M
334.29%8.31M
27.13%2.11M
-10.58%6.55M
-20.49%1.73M
-25.95%1.24M
-1.44%1.91M
8.72%1.66M
Selling and administrative expenses
211.66%8.44M
-57.64%433.04K
-53.01%439.14K
1,023.04%6.59M
494.45%970.4K
-23.95%2.71M
6.75%1.02M
45.66%934.45K
-45.06%587.23K
-83.67%163.24K
-Selling and marketing expense
----
----
-73.34%205.19K
101.62%514.25K
720.17%853.71K
----
----
50.21%769.52K
-61.05%255.06K
-88.06%104.09K
-General and administrative expense
211.66%8.44M
-6.73%2.01M
41.84%233.95K
1,730.56%6.08M
97.27%116.69K
161.39%2.71M
355.02%2.15M
27.63%164.93K
-19.79%332.17K
-53.62%59.15K
Research and development costs
7.82%3.86M
-4.63%596.7K
148.67%641.86K
25.93%1.57M
-27.36%1.06M
-4.76%3.58M
-54.31%625.69K
-73.88%258.12K
42.72%1.24M
173.92%1.45M
Depreciation amortization depletion
557.77%90.92K
6,064.39%48.64K
7,813.33%22.55K
-45.50%6.95K
--12.79K
--13.82K
--789
--285
--12.75K
--0
-Depreciation and amortization
557.77%90.92K
6,064.39%48.64K
7,813.33%22.55K
-45.50%6.95K
--12.79K
--13.82K
--789
--285
--12.75K
--0
Other operating expenses
77.91%432.15K
41.40%110.39K
116.99%106.64K
103.37%139.05K
60.79%76.08K
--242.9K
--78.07K
3.73%49.15K
--68.37K
--47.32K
Operating profit
-95.89%-12.82M
31.16%-1.19M
2.56%-1.21M
-334.29%-8.31M
-27.13%-2.11M
10.58%-6.55M
20.49%-1.73M
25.95%-1.24M
1.44%-1.91M
-8.72%-1.66M
Net non-operating interest income (expenses)
-46.79%-375.97K
-43.61%-148.61K
8.34%-93.13K
-4.47%-53.32K
-80.91K
-256.12K
-103.48K
-101.6K
-51.04K
0
Non-operating interest income
221.43%21.89K
4,985.71%356
-74.67%1.72K
--4.76K
--15.05K
--6.81K
--7
--6.8K
--0
--0
Non-operating interest expense
51.31%397.85K
43.94%148.96K
-12.50%94.86K
13.79%58.08K
--95.96K
--262.93K
--103.49K
--108.41K
--51.04K
--0
Other net income (expenses)
107.24%4.8K
-219.31%-10.87K
-5,447.05%-24.44K
274.76%41.75K
95.83%-1.65K
-377.79%-66.3K
-108.24%-3.4K
102.62%457
-23.89K
-39.46K
Gain on sale of security
107.24%4.8K
-219.31%-10.87K
-5,447.05%-24.44K
274.76%41.75K
95.83%-1.65K
-377.79%-66.3K
-108.24%-3.4K
102.62%457
---23.89K
---39.46K
Income before tax
-92.10%-13.19M
26.48%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
5.87%-6.87M
13.93%-1.83M
20.74%-1.34M
-2.42%-1.99M
-11.30%-1.7M
Income tax
0
-105K
Earnings from equity interest net of tax
Net income
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.31%-6.76M
18.86%-1.73M
20.74%-1.34M
-2.42%-1.99M
-11.30%-1.7M
Net income continuous operations
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.31%-6.76M
18.86%-1.73M
20.74%-1.34M
-2.42%-1.99M
-11.30%-1.7M
Noncontrolling interests
Net income attributable to the company
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
-2.42%-1.99M
-11.30%-1.7M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
-95.08%-13.19M
22.01%-1.35M
1.15%-1.33M
-318.50%-8.32M
-29.03%-2.2M
7.91%-6.76M
20.64%-1.73M
20.74%-1.34M
-2.42%-1.99M
-11.30%-1.7M
Diluted earnings per share
-76.47%-0.3
25.00%-0.03
0.00%-0.03
-280.00%-0.19
0.00%-0.05
15.00%-0.17
33.33%-0.04
40.00%-0.03
0.00%-0.05
-25.00%-0.05
Basic earnings per share
-76.47%-0.3
25.00%-0.03
0.00%-0.03
-280.00%-0.19
0.00%-0.05
15.00%-0.17
33.33%-0.04
40.00%-0.03
0.00%-0.05
-25.00%-0.05
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Jun 30, 2024(Q4)Jun 30, 2024(Q3)Mar 31, 2024(Q2)Dec 31, 2023(Q1)Sep 30, 2023(FY)Jun 30, 2023(Q4)Jun 30, 2023(Q3)Mar 31, 2023(Q2)Dec 31, 2022(Q1)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 95.89%12.82M-31.16%1.19M-2.56%1.21M334.29%8.31M27.13%2.11M-10.58%6.55M-20.49%1.73M-25.95%1.24M-1.44%1.91M8.72%1.66M
Selling and administrative expenses 211.66%8.44M-57.64%433.04K-53.01%439.14K1,023.04%6.59M494.45%970.4K-23.95%2.71M6.75%1.02M45.66%934.45K-45.06%587.23K-83.67%163.24K
-Selling and marketing expense ---------73.34%205.19K101.62%514.25K720.17%853.71K--------50.21%769.52K-61.05%255.06K-88.06%104.09K
-General and administrative expense 211.66%8.44M-6.73%2.01M41.84%233.95K1,730.56%6.08M97.27%116.69K161.39%2.71M355.02%2.15M27.63%164.93K-19.79%332.17K-53.62%59.15K
Research and development costs 7.82%3.86M-4.63%596.7K148.67%641.86K25.93%1.57M-27.36%1.06M-4.76%3.58M-54.31%625.69K-73.88%258.12K42.72%1.24M173.92%1.45M
Depreciation amortization depletion 557.77%90.92K6,064.39%48.64K7,813.33%22.55K-45.50%6.95K--12.79K--13.82K--789--285--12.75K--0
-Depreciation and amortization 557.77%90.92K6,064.39%48.64K7,813.33%22.55K-45.50%6.95K--12.79K--13.82K--789--285--12.75K--0
Other operating expenses 77.91%432.15K41.40%110.39K116.99%106.64K103.37%139.05K60.79%76.08K--242.9K--78.07K3.73%49.15K--68.37K--47.32K
Operating profit -95.89%-12.82M31.16%-1.19M2.56%-1.21M-334.29%-8.31M-27.13%-2.11M10.58%-6.55M20.49%-1.73M25.95%-1.24M1.44%-1.91M-8.72%-1.66M
Net non-operating interest income (expenses) -46.79%-375.97K-43.61%-148.61K8.34%-93.13K-4.47%-53.32K-80.91K-256.12K-103.48K-101.6K-51.04K0
Non-operating interest income 221.43%21.89K4,985.71%356-74.67%1.72K--4.76K--15.05K--6.81K--7--6.8K--0--0
Non-operating interest expense 51.31%397.85K43.94%148.96K-12.50%94.86K13.79%58.08K--95.96K--262.93K--103.49K--108.41K--51.04K--0
Other net income (expenses) 107.24%4.8K-219.31%-10.87K-5,447.05%-24.44K274.76%41.75K95.83%-1.65K-377.79%-66.3K-108.24%-3.4K102.62%457-23.89K-39.46K
Gain on sale of security 107.24%4.8K-219.31%-10.87K-5,447.05%-24.44K274.76%41.75K95.83%-1.65K-377.79%-66.3K-108.24%-3.4K102.62%457---23.89K---39.46K
Income before tax -92.10%-13.19M26.48%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M5.87%-6.87M13.93%-1.83M20.74%-1.34M-2.42%-1.99M-11.30%-1.7M
Income tax 0-105K
Earnings from equity interest net of tax
Net income -95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.31%-6.76M18.86%-1.73M20.74%-1.34M-2.42%-1.99M-11.30%-1.7M
Net income continuous operations -95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.31%-6.76M18.86%-1.73M20.74%-1.34M-2.42%-1.99M-11.30%-1.7M
Noncontrolling interests
Net income attributable to the company -95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M-2.42%-1.99M-11.30%-1.7M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders -95.08%-13.19M22.01%-1.35M1.15%-1.33M-318.50%-8.32M-29.03%-2.2M7.91%-6.76M20.64%-1.73M20.74%-1.34M-2.42%-1.99M-11.30%-1.7M
Diluted earnings per share -76.47%-0.325.00%-0.030.00%-0.03-280.00%-0.190.00%-0.0515.00%-0.1733.33%-0.0440.00%-0.030.00%-0.05-25.00%-0.05
Basic earnings per share -76.47%-0.325.00%-0.030.00%-0.03-280.00%-0.190.00%-0.0515.00%-0.1733.33%-0.0440.00%-0.030.00%-0.05-25.00%-0.05
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data